Thymus protein oral solution

1. Pharmacology: In vitro cell culture tests have shown that this product has a proliferative effect on endothelial and fibroblast cells; animal experimental studies have shown that this product can directly have a significant preventive and therapeutic effect on gastric ulcer models indicated by different factors. Its characteristics are to protect and nourish the gastric mucosa and promote its damage repair by enhancing the activity of gastric mucosal Na-K-ATPase and improving the function of gastric mucus cells, increasing the synthesis of gastric mucosal prostaglandins and reducing the level of plasma endothelin. 2. Toxicology: The maximum tolerated oral acute toxicity of this product is 4000mg/kg (ie LD504000mg/kg). In the oral long-term toxicity test, no obvious abnormalities were found in the observed indicators.

The main ingredient of this product is medium-molecular protein extracted from the thymus of suckling pigs.

This product is a light yellow clear solution.

This product can be used to treat patients with gastric ulcers, and can also be used to treat patients with duodenal ulcers.

Oral administration: 30 mg (one bottle) at a time, twice a day (take 2 to 3 hours after breakfast and dinner), 30 days as a course of treatment.

Not yet clear.

Not yet clear.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Store in a cool place (not exceeding 20°C). Valid for 24 months.

6ml:30mg (based on protein)

24 months

Xiuzheng Pharmaceutical Group Beijing Xiuzheng Pharmaceutical Co., Ltd.

• Founded in:

  2003-09-02

• Address:

  Room 206, West Courtyard Building, No. 23, Hongfu Pioneer Park, Beiqijia Town, Changping District, Beijing

• Tax NO.:

  91110114754164773M

• Registered Funds:

  530 million yuan

• Email:

  Log in to view